Briefing: The memory stock cycle of boom-bust-repeat is over, executives say
Strategic angle: Shares of Micron have skyrocketed 370% over the past year, while Sandisk is up more than 1100%.
Editorial Staff Mar 11
Briefing: Investors demand steep concessions in Salesforce’s $25bn bond deal
Strategic angle: Software group sold debt at significant premium in borrowing costs in sign of Wall Street jitters over AI disruption
Editorial Staff Mar 11
Briefing: Bromacker deposit is 4 million years older than previously thought, new dating reveals
Strategic angle: New analysis shows the Bromacker rocks date back 294 million years, challenging previous estimates.
Editorial Staff Mar 11
Briefing: Why SSR Mining Stock Dropped Today
Strategic angle: An analysis of the recent decline in SSR Mining's stock value.
Editorial Staff Mar 11
Briefing: As Palantir Stock Falters, This Profit Strategy Counts On Further Weakness
Strategic angle: A strategic approach to profit amid Palantir's declining stock performance.
Editorial Staff Mar 11
Briefing: Jim Cramer on Vertiv Holdings: “What a Stock, What a Company”
Strategic angle: Jim Cramer praises Vertiv Holdings for its strong performance and potential.
Editorial Staff Mar 11
Briefing: Eagle Nuclear Energy Corp. Rings the Opening Bell - Nasdaq
Strategic angle: Eagle Nuclear Energy Corp. celebrates a significant milestone by ringing the opening bell at Nasdaq.
Editorial Staff Mar 11
Briefing: South Dakota Energy Co. Shares Poised to Nearly Double on Rising Uranium Production & Dewey Burdock Progress
Strategic angle: Analysts predict significant growth for South Dakota Energy Co. as uranium production increases.
Editorial Staff Mar 11
Mortgage and refinance interest rates today, March 9, 2026: Moving higher with bond market anxiety
Mortgage and refinance interest rates are on the rise as concerns grow in the bond market.
Editorial Staff Mar 11
HELOC and home equity loan rates Monday, March 9, 2026: Got a low rate? Now consider this.
Explore current HELOC and home equity loan rates and what to consider if you have a low rate.
Editorial Staff Mar 11
Briefing: How high could Europe's inflation go if the Iran war continues?
Strategic angle: Economists warn that ongoing conflict may lead to soaring inflation rates in the eurozone.
Editorial Staff Mar 11
Briefing: Why Hycroft Mining Stock Triumphed on Tuesday
Strategic angle: A significant rise in Hycroft Mining stock has caught investors' attention.
Editorial Staff Mar 10
Briefing: Volkswagen Plans Up To 50,000 Job Cuts After Profits Fell Off A Cliff
Strategic angle: Tariffs, China competition and EV headaches push VW into cost-cutting mode
Editorial Staff Mar 10
Briefing: These Cruise Line Stocks Are Falling Amid War-Driven Volatility
Strategic angle: Investors are reacting to geopolitical tensions affecting the cruise industry.
Editorial Staff Mar 10
Briefing: BioNTech Cofounders To Step Down. Stock Crumbles.
Strategic angle: BioNTech's cofounders are stepping down, leading to a significant drop in stock prices.
Editorial Staff Mar 10
Briefing: Why This Tech Stock Could Enjoy a Short-Term Pop
Strategic angle: An analysis of potential short-term gains in a promising tech stock.
Editorial Staff Mar 10
Briefing: Option traders moderately bearish in Warner Bros. Discovery with shares down 0.55%
Strategic angle: Option traders show a cautious outlook on Warner Bros. Discovery as shares decline slightly.
Editorial Staff Mar 10
Briefing: Inside Alts: Boaz Weinstein warns of private credit’s 'financial alchemy,' says problems are multiplying by the quarter
Strategic angle: Saba, alongside Cox Capital Management, launched a tender offer to purchase shares in one of Blue Owl's non-traded private credit funds at a 34.9% discount.
Editorial Staff Mar 10
Briefing: Argentina's Milei is pitching to Wall Street as Middle East spooks investors
Strategic angle: Milei seeks to attract investment amidst geopolitical tensions affecting market confidence.
Editorial Staff Mar 10
Briefing: BioNTech Shares Fall After Cofounders Plan Exit, Outlook Misses Forecasts
Strategic angle: BioNTech's stock takes a hit as cofounders announce their departure and the company's outlook fails to meet expectations.
Editorial Staff Mar 10